Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • NHS Solutions
  • Life Sciences Industry
  • Advancing UK Healthcare
  • Pharmacy Communications
NHS Solutions

Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.

Learn More
NHS Solutions
Life Sciences Industry

We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.

Learn More
Life Sciences Industry Solutions
Advancing UK Healthcare

We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.

Learn More
Advancing UK Healthcare Solutions
Pharmacy Communications

IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.

Learn More
MAIN/Insights
Insights/
BLOGS, WHITEPAPERS & CASE STUDIES

Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.

Learn More
NEWSROOM

Stay up to date on the latest news and press releases from IQVIA UK & Ireland.

Learn More

Report

"Our commitment to sustainability.

Learn More
MAIN/Contact Us
Contact Us/
Video
Navigating Rare Disease Policy Landscape
May 23, 2025

The recent discussions around the Ten Year Plan for the NHS and the potential merging of Integrated Care Boards present unique opportunities for the rare disease community. The shift from sickness to prevention, especially in the context of early diagnosis and treatment, can have a significant impact on patients, families, and healthcare systems. As we navigate these changes, it's crucial that rare diseases are not forgotten and are included in the broader healthcare discussions. Looking forward to seeing how we can continue to advocate for rare diseases in the evolving healthcare landscape. With Rosie Lindup, Senior Government Affairs Manager, BioIndustry Association (BIA), Deborah Richards, Rare Diseases GM, UK&I Alexion Pharmaceuticals, Inc. and Steven Ferguson, Director, Value and Access, IQVIA.

Navigating Rare Disease Policy Landscape

You may also be interested in

Institute Report
America's Greatness in the Biopharmaceutical Sector
Video
Looking Ahead into 2025 for HealthTech
White Paper
Evolving Beyond the PBS: Exploring Australia’s Private Medicines Market
Blog
Unlock the Future of Healthcare with Advanced Utilization Forecasting
Blog
Top 3 Data-Driven Strategies and Actionable Tips for Health System Growth
White Paper
Customer Engagement in the Era of Unlimited Data and Artificial Intelligence
Prev
Next

Related solutions

Contact Us